HCP1803 / Hanmi  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HCP1803 / Hanmi
HM_APOLLO, NCT03897868: A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension

Completed
2
248
RoW
HCP1803, Amlodipine, Losartan, Placebo
Hanmi Pharmaceutical Company Limited
Hypertension
02/20
02/20
HM_APOLLO, NCT04959305: A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension

Completed
2
245
RoW
HCP1803-3, RLD2003, RLD2004, RLD2005, HPP2003-3, HPP2005
Hanmi Pharmaceutical Company Limited
Hypertension
02/22
02/22

Download Options